Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Ryan David Nipp

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4577-3248; OpenAlex author ID A5000172075. Sources: ClinicalTrials.gov.

Their work

Papers
20 (first author 3, last author 4)
Trials
3 (principal investigator on 3)
Grants
0
Labs led
2
Collaborators
62
Papers, trials and grants by year

2015: 1 paper · 2016: 1 trial · 2017: 1 paper · 2018: 4 papers · 2019: 3 papers, 1 trial · 2020: 1 trial · 2021: 2 papers · 2022: 4 papers · 2023: none · 2024: 3 papers · 2025: 1 paper · 2026: 1 paper

Papers 20

  1. Chemotherapy and Supportive Care Practice Patterns Among Older Adults With Metastatic Pancreatic Cancer. Last author DOI 10.1200/op-25-00534↗
  2. Impact of electronic patient-reported outcomes (ePRO) presentation in pancreatic cancer tumor board discussions on cancer outcomes: the INSPIRE intervention. Co-author DOI 10.1186/s12885-025-14847-w↗
  3. The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia. Co-author DOI 10.1016/j.ccell.2024.03.009↗
  4. Bridging the Divide: From Universal Germline Testing Guidance to Real-World Implementation in Pancreatic Cancer Care. First author DOI 10.1200/op.24.00237↗
  5. Implementation of ePROs Into Multidisciplinary Tumor Board Discussions for Patients With Pancreatic Cancer: The INSPIRE Intervention. Co-author DOI 10.6004/jnccn.2024.7052↗
  6. Palliative and Supportive Care for Individuals with Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.hoc.2022.07.009↗
  7. Communicating the Information Needed for Treatment Decision Making Among Patients With Pancreatic Cancer Receiving Preoperative Therapy. Last author DOI 10.1200/op.21.00388↗
  8. Opioid Prescriptions and Survival in Pancreatic Cancer. Last author DOI 10.1200/op.21.00862↗
  9. Supportive Oncology Care at Home Intervention for Patients With Pancreatic Cancer. Co-author DOI 10.1200/op.22.00088↗
  10. Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experienc… Last author DOI 10.1002/cam4.4257↗
  11. Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Co-author DOI 10.1038/s43018-021-00269-7↗
  12. Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical… Co-author DOI 10.1001/jamaoncol.2019.0892↗
  13. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX. Co-author DOI 10.1097/sla.0000000000002600↗
  14. Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis. First author DOI 10.1634/theoncologist.2018-0114↗
  15. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Co-author DOI 10.1002/cam4.1277↗
  16. Patterns and predictors of end-of-life care in older patients with pancreatic cancer. Co-author DOI 10.1002/cam4.1861↗
  17. Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Ca… Co-author DOI 10.1097/coc.0000000000000349↗
  18. Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer. First author DOI 10.1245/s10434-018-6832-8↗
  19. Predictors of Early Mortality After Surgical Resection of Pancreatic Adenocarcinoma in the Era of Neoadjuvant Treatment. Co-author DOI 10.1097/mpa.0000000000000731↗
  20. Predicting a response to FOLFIRINOX in pancreatic cancer. Co-author DOI 10.1093/jnci/djv175↗

Trials 3

  1. Supportive Oncology Care At Home RCT Principal investigator NCT04544046↗
  2. Supportive Oncology Care at Home for Patients With Pancreatic Cancer Receiving Preoperative FOLFIRINOX Principal investigator NCT03798769↗
  3. Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection Principal investigator NCT02810652↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David P. Ryan · 8 shared papers, 2015–2022 · strength 0.66
  2. Theodore Sunki Hong · 8 shared papers, 2017–2022 · strength 0.64
  3. Jennifer Yon-Li Wo · 7 shared papers, 2017–2022 · strength 0.55
  4. Gabrielle Betty Rocque · 2 shared papers, 2024–2025 · strength 0.46
  5. John Bart Rose · 2 shared papers, 2024–2025 · strength 0.46
  6. Garrett Bourne · 2 shared papers, 2024–2025 · strength 0.46
  7. Nicole L. Henderson · 2 shared papers, 2024–2025 · strength 0.46
  8. Harshabad Singh · 1 shared paper, 2024 · strength 0.46
  9. Cristina Rosa Ferrone · 6 shared papers, 2017–2019 · strength 0.43
  10. Aparna R. Parikh · 5 shared papers, 2018–2022 · strength 0.42
  11. Colin D. Weekes · 4 shared papers, 2019–2022 · strength 0.39
  12. Arjun Gupta · 2 shared papers, 2021–2022 · strength 0.38
  13. Carlos F. Fernandez-del Castillo · 5 shared papers, 2017–2019 · strength 0.37
  14. Charles E. Gaber · 1 shared paper, 2026 · strength 0.33
  15. Jakob Kirkegård · 1 shared paper, 2026 · strength 0.33
  16. Lawrence Scott Blaszkowsky · 4 shared papers, 2018–2021 · strength 0.29
  17. Chung Yin Kong · 3 shared papers, 2018–2019 · strength 0.29
  18. Angela C. Tramontano · 3 shared papers, 2018–2019 · strength 0.29
  19. Chin Hur · 3 shared papers, 2018–2019 · strength 0.29
  20. Keith D. Lillemoe · 4 shared papers, 2017–2019 · strength 0.27
  21. David Tsai Ting · 3 shared papers, 2019–2022 · strength 0.27
  22. Areej R El-Jawahri · 2 shared papers, 2022 · strength 0.24
  23. Jennifer Temel · 2 shared papers, 2022 · strength 0.24
  24. Eric J. Roeland · 2 shared papers, 2021–2022 · strength 0.23
  25. Janet E. Murphy · 3 shared papers, 2018–2019 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.